Liwei Hu
- Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism 2
-
- Pancreatic and Hepatic Oncology Research 5
-
- Wound Healing and Treatments 3
-
- Antimicrobial agents and applications 4
- Catalytic C–H Functionalization Methods 2
-
- Pancreatitis Pathology and Treatment 3
-
- Plant-Microbe Interactions and Immunity 2
-
- Asymmetric Hydrogenation and Catalysis 2
Liwei Hu
27 papers receiving 474 citations
Peers
Comparison fields: 5 of 101
- Cancer Research 99
- Pharmacology 48
- Oncology 132
- Complementary and alternative medicine 37
- Rehabilitation 23
Countries citing papers authored by Liwei Hu
This map shows the geographic impact of Liwei Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liwei Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liwei Hu more than expected).
Fields of papers citing papers by Liwei Hu
This network shows the impact of papers produced by Liwei Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liwei Hu. The network helps show where Liwei Hu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Liwei Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 15 | |
| 6 | 2024 | 7 | |
| 7 | 2024 | 2 | |
| 8 | 2022 | 23 | |
| 9 | 2022 | 6 | |
| 10 | 2022 | 1 | |
| 11 | 2022 | 5 | |
| 12 | 2022 | 2 | |
| 13 | 2016 | 4 | |
| 14 | 2013 | 33 | |
| 15 | 2013 | 28 | |
| 16 | 2013 | 31 | |
| 17 | 2011 | 24 | |
| 18 | 2009 | 50 | |
| 19 | 2009 | 12 | |
| 20 | 2008 | 11 |
About Liwei Hu
Liwei Hu is a scholar working on Rehabilitation, Pharmacology and Oncology, having authored 30 papers that have together received 478 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (5 papers), Antimicrobial agents and applications (4 papers), Wound Healing and Treatments (3 papers), Pancreatitis Pathology and Treatment (3 papers), Catalytic C–H Functionalization Methods (2 papers), Plant-Microbe Interactions and Immunity (2 papers), Pharmacogenetics and Drug Metabolism (2 papers) and Asymmetric Hydrogenation and Catalysis (2 papers). The work is most often cited by research in Cancer Research (99 citations), Pharmacology (48 citations) and Oncology (132 citations). Liwei Hu has collaborated with scholars based in China and United States. Frequent co-authors include Longjiang Chen, Ren-bao Yang, Jiong Chen, Wen Wu, Hangcheng Zhou, Lu Yin, Yun-lian Xia, Weidong Zhang, Haiyun Li and Juan Su. Their work appears in journals such as Journal of the American Chemical Society, Biochemical and Biophysical Research Communications and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.